Mitchell Hill

Array ( [id] => 1364902 [patent_doc_number] => 06566055 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Methods of preparing nucleic acids for mass spectrometric analysis' [patent_app_type] => B1 [patent_app_number] => 09/089730 [patent_app_country] => US [patent_app_date] => 1998-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 15407 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566055.pdf [firstpage_image] =>[orig_patent_app_number] => 09089730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4357920 [patent_doc_number] => 06218517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => 'Protein having a vascularization inhibitory effect and a method for production thereof and a method for producing angiostatin' [patent_app_type] => 1 [patent_app_number] => 9/086514 [patent_app_country] => US [patent_app_date] => 1998-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7960 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 203 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218517.pdf [firstpage_image] =>[orig_patent_app_number] => 086514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4143028 [patent_doc_number] => 06030949 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Macrophage stimulating protein for the treatment of pathologies of the nervous system' [patent_app_type] => 1 [patent_app_number] => 9/084233 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1674 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030949.pdf [firstpage_image] =>[orig_patent_app_number] => 084233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4271237 [patent_doc_number] => 06306993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Method and composition for enhancing transport across biological membranes' [patent_app_type] => 1 [patent_app_number] => 9/083259 [patent_app_country] => US [patent_app_date] => 1998-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 23 [patent_no_of_words] => 17540 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306993.pdf [firstpage_image] =>[orig_patent_app_number] => 083259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409278 [patent_doc_number] => 06172185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Antimicrobial cationic peptide derivatives of bactenecin' [patent_app_type] => 1 [patent_app_number] => 9/082420 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10738 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/172/06172185.pdf [firstpage_image] =>[orig_patent_app_number] => 082420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1197134 [patent_doc_number] => 06727285 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Use of D-arginine and/or L-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls' [patent_app_type] => B1 [patent_app_number] => 09/079329 [patent_app_country] => US [patent_app_date] => 1998-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 14028 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/727/06727285.pdf [firstpage_image] =>[orig_patent_app_number] => 09079329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237131 [patent_doc_number] => 06165976 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Therapeutic preparation for inhalation' [patent_app_type] => 1 [patent_app_number] => 9/072717 [patent_app_country] => US [patent_app_date] => 1998-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7213 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165976.pdf [firstpage_image] =>[orig_patent_app_number] => 072717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6890533 [patent_doc_number] => 20010007764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-12 [patent_title] => 'THROMBIN INHIBITORS' [patent_app_type] => new-utility [patent_app_number] => 09/068074 [patent_app_country] => US [patent_app_date] => 1998-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22916 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0007/20010007764.pdf [firstpage_image] =>[orig_patent_app_number] => 09068074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410188 [patent_doc_number] => 06228841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Peptide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/029604 [patent_app_country] => US [patent_app_date] => 1998-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10860 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228841.pdf [firstpage_image] =>[orig_patent_app_number] => 029604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051791 [patent_doc_number] => 05932549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-03 [patent_title] => 'N-substituted glutamic acid derivatives with interleukin-1.beta. converting enzyme inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 9/067053 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5793 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 539 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/932/05932549.pdf [firstpage_image] =>[orig_patent_app_number] => 067053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1581485 [patent_doc_number] => 06423686 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'LHRH antagonist peptides' [patent_app_type] => B1 [patent_app_number] => 08/973378 [patent_app_country] => US [patent_app_date] => 1998-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16066 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423686.pdf [firstpage_image] =>[orig_patent_app_number] => 08973378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4192375 [patent_doc_number] => 06130204 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-10 [patent_title] => 'Peptides' [patent_app_type] => 1 [patent_app_number] => 9/051342 [patent_app_country] => US [patent_app_date] => 1998-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25211 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/130/06130204.pdf [firstpage_image] =>[orig_patent_app_number] => 051342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996957 [patent_doc_number] => 05922678 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Methods for treating diabetes' [patent_app_type] => 1 [patent_app_number] => 9/047243 [patent_app_country] => US [patent_app_date] => 1998-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13425 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922678.pdf [firstpage_image] =>[orig_patent_app_number] => 047243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088236 [patent_doc_number] => 06025467 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Parathyroid hormone derivatives and their use' [patent_app_type] => 1 [patent_app_number] => 9/044536 [patent_app_country] => US [patent_app_date] => 1998-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15024 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025467.pdf [firstpage_image] =>[orig_patent_app_number] => 044536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4142889 [patent_doc_number] => 06030942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Peptides peptide analogs peptidomimetics and other small molecules useful for inhibiting the activity of ribonucleotide reductase' [patent_app_type] => 1 [patent_app_number] => 9/040216 [patent_app_country] => US [patent_app_date] => 1998-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 52 [patent_no_of_words] => 52759 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/030/06030942.pdf [firstpage_image] =>[orig_patent_app_number] => 040216 [rel_patent_id] =>[rel_patent_doc_number] =>)